Physician profile
Vicky E Sherman
NPI 1164443594
$1,522.38
in general payments reported to CMS, 2019-2025
32 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $86.65 · 2021: $454 · 2022: $292 · 2023: $177 · 2024: $105 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $181.35 | 2019-2023 | Orilissa |
| Exeltis, USA INC. | $145.01 | 2020-2025 | Slynd |
| Mayne Pharma Commercial LLC | $106.81 | 2021-2025 | |
| Pfizer INC. | $81.85 | 2020-2023 | |
| Astellas Pharma US INC | $80.49 | 2024-2025 | Veozah |
| Organon LLC | $78.46 | 2021-2025 | Nexplanon |
| Alydia Health | $70.56 | 2021 | |
| Hologic Sales and Service, LLC | $67.12 | 2019-2022 | |
| Avion Pharmaceuticals | $66.83 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.90 | 2019-2025 | |
| Myovant Sciences INC. | $62.42 | 2021-2022 | |
| Davol INC. | $57.78 | 2020-2023 | Arista Ah Flexitip |
| Biogen, INC. | $53.53 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $36.54 | 2020-2023 | Paragard T 380a |
| Millicent US INC | $35.21 | 2024-2025 | Intrarosa, Femlyv |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $30.02 | 2022 | |
| Therapeuticsmd, INC. | $27.02 | 2021-2022 | |
| Duchesnay USA Incorporated | $24.61 | 2019 | |
| Agile Therapeutics, INC. | $24.01 | 2021 | |
| Evofem Biosciences, INC. | $22.64 | 2021 | |
| Sumitomo Pharma America, INC. | $22.13 | 2024 | Myfembree |
| Meditrina | $20.13 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.00 | 2022 | |
| Merck Sharp & Dohme LLC | $18.63 | 2021 | |
| Medicem INC. | $18.31 | 2021 | |
| Virtus Pharmaceuticals LLC | $15.94 | 2021 | |
| Amag Pharmaceuticals, INC. | $15.87 | 2020 | |
| Boston Scientific Corporation | $15.68 | 2019 | |
| Shield Therapeutics INC | $15.52 | 2023 | Accrufer |
| Exact Sciences Corporation | $14.97 | 2025 | The Cologuard Plus Collection Kit |
| Sage Therapeutics, LLC | $14.32 | 2021 | |
| Novo Nordisk INC | $13.72 | 2023 | Wegovy, Saxenda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vicky Sherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.